The slipper lobster, Scyllarides latus, uses apatite and fluorapatite to protect its sensory organules

The cuticle of arthropods has been intensely studied not only to better understand the properties of a natural composite material, but also to understand how structural properties and mineral contributions to this composite offer a durable protective covering from predator and microbial attack. Thus far, most marine cuticular studies have focused on the American lobster, Homarus americanus, or several crab species, but have largely ignored other types of lobsters, such as spiny or slipper lobsters that have exoskeletons differing in both structural properties (i.e., amount of trabeculae present in pits and spines) and resistance to structural failure. Using an electron microprobe, we analyzed various segments of the exoskeleton of the Mediterranean slipper lobster, Scyllarides latus, to determine the mineral content in discrete domains of cuticle. EMP analysis determined that the cuticle of S. latus is similar to that of H. americanus in that it contains carbonate apatite in canal linings and in the areas surrounding sensory organules (setae). The slipper lobster also uses a fluorapatite mineral that further adds strength to the shell. Results will be discussed in the context of what this means for defense against attack and differences in environmental water chemistry and resilience to climate change

Does hemispheric lateralization influence functional and cardiovascular outcomes after stroke?: an analysis of placebo-treated patients from prospective acute stroke trials

<p><b>Background and Purpose:</b> The influence of stroke lateralization on functional and cardiovascular outcome after stroke is not well established. We evaluated the influence of hemispheric lateralization among patients enrolled in prospective acute stroke trials.</p> <p><b>Methods:</b> We obtained data from the VISTA database for acute stroke trials which reported lateralization. Baseline data, cardiac adverse events, and 90-day outcomes were compared between right and left hemisphere stroke patients. A "hemisphere unbiased" subscore of the NIHSS which omitted items strongly associated with lateralized cognitive deficits was also compared for trials which reported individual NIHSS item scores. A multivariable analysis of outcome predictors was performed.</p> <p><b>Results:</b> Three acute stroke trials met the prespecified inclusion criteria. 1644 placebo-treated patients with documented hemispheric lateralization were included in the analysis. Baseline NIHSS was higher for left hemisphere patients (mean 16.2, versus 12.8 right, P < 0.001); there was no difference in the "hemisphere unbiased" NIHSS subscore (10.88 left, 11.08 right, n=687, P= 0.49). There was no difference between hemispheres in 90-day modified Rankin Score (3.43 left, 3.29 right, P=0.13), mortality (22.1% left, 19.5% right, P=0.20), or cardiac adverse events (P=0.71). Hemispheric lateralization was not an independent predictor of outcome in the multivariable analysis after controlling for the hemispheric bias intrinsic to the NIHSS.</p> <p><b>Conclusions:</b> There is no difference in functional outcome between patients with right or left hemisphere stroke. Use of the baseline NIHSS score to predict stroke outcome must take hemispheric lateralization into account. Stroke lateralization is not an important predictor of cardiac adverse events or 90-day mortality.</p&gt

NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials

<p><b>Background and Purpose:</b> In animal models of acute ischemic stroke (AIS), the free radical-trapping agent NXY-059 showed promise as a neuroprotectant. SAINT I and II were randomized, placebo-controlled, double-blind trials to investigate the efficacy of NXY-059 in patients with AIS.</p> <p><b>Methods:</b> Patients with AIS received an infusion of intravenous NXY-059 or placebo within 6 hours from the onset of stroke symptoms. A pooled individual patient analysis was prespecified to assess the overall efficacy and to examine subgroups. The primary end point was the distribution of disability scores measured on the modified Rankin scale (mRS) at 90 days. Neurologic and activities of daily living scores were investigated as secondary end points. We also evaluated whether treatment with NXY-059 would reduce alteplase-related intracranial hemorrhages. Finally, we evaluated possible predictors of good or poor outcome.</p> <p><b>Results:</b> An intent-to-treat efficacy analysis was based on 5028 patients. Baseline parameters and prognostic factors were well balanced between treatment groups. The distribution of scores on the mRS was not different in the group treated with NXY-059 (n = 2438) compared with the placebo group (n = 2456): odds ratio for limiting disability = 1.02; 95% CI, 0.92 to 1.13 (P = 0.682, Cochran-Mantel-Haenszel test). Comparisons at each level of the mRS confirmed an absence of benefit. There was no evidence of efficacy in prespecified subgroups or from the secondary outcome analyses. Mortality was equal in the 2 groups (16.7% vs 16.5%), and adverse event rates were similar. Among patients treated with alteplase, there was no decrease in rates of symptomatic or asymptomatic hemorrhage associated with NXY-059 treatment versus placebo. Subgroup analyses identified National Institutes of Health Stroke Scale score, age, markers of inflammation, blood glucose, and right-sided infarct as predictors of poor outcome.</p> <p><b>Conclusions:</b> NXY-059 is ineffective for treatment of AIS within 6 hours of symptom onset. This is also true for subgroups and the prevention of alteplase-associated hemorrhage.</p&gt

Spartan Daily, October 6, 1958

Volume 46, Issue 9https://scholarworks.sjsu.edu/spartandaily/12638/thumbnail.jp

1952 Statistics

1952 Men\u27s Basketball Statistics, George Fox College

Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s.

Group 2 innate lymphoid cells (ILC2s) and type 2 helper T cells (Th2 cells) are the primary source of interleukin 5 (IL-5) and IL-13 during type 2 (allergic) inflammation in the lung. In Th2 cells, T cell receptor (TCR) signaling activates the transcription factors nuclear factor of activated T cells (NFAT), nuclear factor κB (NF-κB), and activator protein 1 (AP-1) to induce type 2 cytokines. ILC2s lack a TCR and respond instead to locally produced cytokines such as IL-33. Although IL-33 induces AP-1 and NF-κB, NFAT signaling has not been described in ILC2s. In this study, we report a nonredundant NFAT-dependent role for lipid-derived leukotrienes (LTs) in the activation of lung ILC2s. Using cytokine reporter and LT-deficient mice, we find that complete disruption of LT signaling markedly diminishes ILC2 activation and downstream responses during type 2 inflammation. Type 2 responses are equivalently attenuated in IL-33- and LT-deficient mice, and optimal ILC2 activation reflects potent synergy between these pathways. These findings expand our understanding of ILC2 regulation and may have important implications for the treatment of airways disease

The Mark 3 Haploscope

A computer-operated binocular vision testing device was developed as one part of a system designed for NASA to evaluate the visual function of astronauts during spaceflight. This particular device, called the Mark 3 Haploscope, employs semi-automated psychophysical test procedures to measure visual acuity, stereopsis, phoria, fixation disparity, refractive state and accommodation/convergence relationships. Test procedures are self-administered and can be used repeatedly without subject memorization. The Haploscope was designed as one module of the complete NASA Vision Testing System. However, it is capable of stand-alone operation. Moreover, the compactness and portability of the Haploscope make possible its use in a broad variety of testing environments

Millimeter wave propagation measurements and characteristics for 5G system

In future 5G systems, the millimeter wave (mmWave) band will be used to support a large capacity for current mobile broadband. Therefore, the radio access technology (RAT) should be made available for 5G devices to help in distinct situations, for example device-to-device communications (D2D) and multi-hops. This paper presents ultra-wideband channel measurements for millimeter wave bands at 19, 28, and 38 GHz. We used an ultra-wideband channel sounder (1 GHz bandwidth) in an indoor to outdoor (I2O) environment for non-line-of-sight (NLOS) scenarios. In an NLOS environment, there is no direct path (line of sight), and all of the contributed paths are received from different physical objects by refection propagation phenomena. Hence, in this work, a directional horn antenna (high gain) was used at the transmitter, while an omnidirectional antenna was used at the receiver to collect the radio signals from all directions. The path loss and temporal dispersion were examined based on the acquired measurement data—the 5G propagation characteristics. Two different path loss models were used, namely close-in (CI) free space reference distance and alpha-beta-gamma (ABG) models. The time dispersion parameters were provided based on a mean excess delay, a root mean square (RMS) delay spread, and a maximum excess delay. The path loss exponent for this NLOS specific environment was found to be low for all of the proposed frequencies, and the RMS delay spread values were less than 30 ns for all of the measured frequencies, and the average RMS delay spread values were 19.2, 19.3, and 20.3 ns for 19, 28, and 38 GHz frequencies, respectively. Moreover, the mean excess delay values were found also at 26.1, 25.8, and 27.3 ns for 19, 28, and 38 GHz frequencies, respectively. The propagation signal through the NLOS channel at 19, 28, and 38 GHz was strong with a low delay; it is concluded that these bands are reliable for 5G systems in short-range applications